GTP

• Cisplatin
• Gemcitabine
• Paclitaxel

Name

Cisplatin

Alternate Names

Cis-Platin

Cis-Platinum II#

Cisplatino (Spanish)

Cisplatinum

Cisplatyl

Neoplatin

Peyrone's chloride

Platinex

Platinol

Platinol-AQ

Platinol-AQ VHA Plus

Platinum

Abbreviations

CACP

CDDP

Cis-DDP

CPD

CPDC

CPDD

CPPD

DDP

Category

Chemotherapy

Subcategory

Alkylating agent

Platinum analog

NSC Number

119875

Primary Site

Bladder

ovarian

testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Gemcitabine

Alternate Names

Gemcitabine Hydrochloride

Gemzar

LY 188011

LY-188011

LY188011 hydrochloride

Gemcitabine HCL

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

613327

Primary Site

Bladder

Breast

non-small cell lung

ovarian

pancreatic cancer

Soft Tissue Sarcoma

Histology

None

Remarks

FDA approved for breast. ovarian, pancreas, NSC lung
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.

Coding

This drug should be coded

Name

Paclitaxel

Alternate Names

BMS-181339-01

BMY-45622

Taxol

Abbreviations

None

Category

Chemotherapy

Subcategory

Mitotic inhibitor

plant alkaloid

Taxane

NSC Number

125973

673089

Primary Site

breast

Gastric

head & neck cancer

Kaposi's sarcoma

non-small cell lung cancers

ovarian

Histology

None

Remarks

Phase I (gastric) FDA approved uses on breast, ovarian, non-small cell lung cancers, and Kaposi's sarcoma. Bristol-Myers Squibb.

Coding

This drug should be coded